Photocatalytic-Driven Antiviral Activities of Heterostructured BiOCl

Abstract read

In one paragraph

Article in ACS omega, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it

0cells of the map it votes in

1citing papers in PubMed

–field-weighted citation impact

1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

Carbon Dots-TiOMaterials (Basel, Switzerland) · 2026
Article

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Razan AbbasiCasali Center of Applied Chemistry, Institute of Chemistry, The Hebrew University of Jerusalem, Jerusalem 9190401, Israel.ORCID https://orcid.org/0000-0003-3363-2613

Hani GnayemCasali Center of Applied Chemistry, Institute of Chemistry, The Hebrew University of Jerusalem, Jerusalem 9190401, Israel.ORCID https://orcid.org/0000-0001-5580-6245

Yoel SassonCasali Center of Applied Chemistry, Institute of Chemistry, The Hebrew University of Jerusalem, Jerusalem 9190401, Israel.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Numerous methods for eliminating severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) are being extensively examined in recent years as a result of the COVID-19 pandemic and its adverse effects on society. Photocatalysis is among the most encouraging solutions since it has the capacity to fully annihilate pathogens, surpassing conventional disinfecting methods. A heterostructured photocatalytic composite of (70%W BiOCl

Identifiers

PMID38680376

DOI10.1021/acsomega.3c10310

PMCPMC11044170

What OpenQuestion holds

Textmetadata

LicenceCC BY

Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.